1,964
Views
28
CrossRef citations to date
0
Altmetric
Research Paper

Novel heterocyclic hybrids of pyrazole targeting dihydrofolate reductase: design, biological evaluation and insilico studies

ORCID Icon, , ORCID Icon, , &
Pages 1491-1502 | Received 28 May 2020, Accepted 22 Jun 2020, Published online: 16 Jul 2020

References

  • Naeem A, Badshah SL, Muska M, et al. The current case of quinolones: synthetic approaches and antibacterial activity. Molecules 2016;21:268.
  • Welte T, Pletz MW. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. Int J Antimicrob Agents 2010; 36:391–400.
  • Frere JM. Beta-lactamases and bacterial resistance to antibiotics. Mol Microbial 1995; 16:385–95.
  • Devasahayam G, Scheld WM, Hoffman PS. Newer antibacterial drugs for a new century. Expert Opin Invest Drugs 2010;19:215–34.
  • Foye WO, Lemke TL, Williams DA, Principles of medicinal chemistry. 4th ed. Media (PA): Williams and Wilkins; 2005:442–456.
  • Champe PC, Harvey RA, Lippincott’s illustrated reviews: biochemistry. 2nd ed. Philadelphia (PA): Lippincott Williams and Wilkins; 1994:350–356.
  • Berman EM, Werbel LM. The renewed potential for folate antagonists in contemporary cancer chemotherapy. J Med Chem 1991;34:479–85.
  • El-Gazzar YI, Georgey HH, El-Messery SM, et al. Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors. Bioorg Chem 2017; 72:282–92.
  • Al-Rashood ST, Aboldahab IA, Nagi MN, et al. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg Med Chem 2006;14:8608–21.
  • Siliveri S, Bashaboina N, Vamaraju HB, Raj S. Design, synthesis, molecular docking, ADMET studies and biological evaluation of pyrazoline incorporated 1,2,3-triazole benzene sulphonamides. Int J Pharm Pharm Sci 2019;11:6–15.
  • Karthikeyan MS, Holla BS, Kumari NS. Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxy pyrazolines. Eur J Med Chem 2007;42:30–6.
  • Ragavan RV, Vijayakumar V, Kumari NS. Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles. Eur J Med Chem 2010; 45:1173–80.
  • Lee YT, Chung YK. Silver(I)-catalyzed facile synthesis of pyrazoles from propargyl N-sulfonylhydrazones. J Org Chem 2008; 73:4698–701.
  • Ezawa M, Garvey DS, Janero DR, et al. Design of a heteroaryl modified 1, 5-disubstituted pyrazole cyclooxygenase-2 (COX-2) selective inhibitors. Lett Drug Design Dis 2005; 2:40–3.
  • Кorobko D, J. Hadjipavlou-litina D, Logoyda L`. Antioxidant and anti-inflammatory properties of a series of new 7,8-disubstituted theophylline containing a pyrazole ring. Asian J Pharm Clin Res 2018; 11:448–50.
  • Menozz G, Merello L, Fossa P, et al. Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles. Bioorg Med Chem 2004;12:5465–83.
  • Naoum F, Kasiotis KM, Magiatis P, Haroutounian SA. Synthesis of novel nitro-substituted triaryl pyrazole derivatives as potential estrogen receptor ligands. Molecules 2007; 12:1259–73.
  • Cocconcelli G, Diodato E, Caricasole A, et al. Aryl azoles with neuroprotective activity-parallel synthesis and attempts at target identification. Bioorg Med Chem 2008; 16:2043–52.
  • Manojkumar P, Ravi TK, Gopalakrishnan S. Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety. Eur J Med Chem 2009; 44:4690–4.
  • Liu H, Ren Z-L, Wang W, et al. Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: design, synthesis and antibacterial activity. Eur J Med Chem 2018; 157:81–7.
  • Sharshira EM, Hamada N. Synthesis and antimicrobial evaluation of some pyrazole derivatives. Molecules 2012; 17:4962–71.
  • Farag AM, Mayhoub AS, Barakat SE, Bayomi AH. Synthesis of new N-phenylpyrazole derivatives with potent antimicrobial activity. Bioorg. Med. Chem 2008; 16:4569–78.
  • Vijesh AM, Isloor AM, Shetty P, et al. New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents. Eur J Med Chem 2013; 62:410–5.
  • Holla BS, Mahalinga M, Karthikeyan MS, et al. Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents. Bioorg. Med. Chem 2006; 14:2040–7.
  • Zhang T-Y, Zheng C-J, Wu J, et al. Synthesis of novel dihydrotriazine derivatives bearing 1,3-diaryl pyrazole moieties as potential antibacterial agents. Bioorg Med Chem Lett 2019; 29:1079–84.
  • Sapariya NH, Vaghasiya BK, Thummar RP, et al. Synthesis, characterization, in silico molecular docking study and biological evaluation of a 5-(phenylthio) pyrazole based polyhydroquinoline core moiety. New J Chem 2017; 41:10686–94.
  • Bhatt JD, Chudasama CJ, Patel KD. Microwave assisted synthesis of pyrimidines in ionic liquid and their potency as non-classical malarial antifolates. Arch Pharm Chem Life Sci 2016; 349:791–800.
  • Kandile NG, Mohamed MI, Zaky H, Mohamed HM. Novel pyridazine derivatives: Synthesis and antimicrobial activity evaluation. Eur J Med Chem 2009; 44:1989–96.
  • Nagawade RR, Khanna VV, Bhagwat SS, Shinde DB. Synthesis of new series of 1-Aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid as potential antibacterial agents. Eur J Med Chem 2005; 40:1325–30.
  • Arshad M, Bhat AR, Hoi KK, et al. Synthesis, characterization and antibacterial screening of some novel 1,2,4-triazine derivatives. Chin Chem Lett 2017; 28:1559–65.
  • Kaushik CP, Pahwa A. Convenient synthesis, antimalarial and antimicrobial potential of thioethereal 1,4-disubstituted 1,2,3-triazoles with ester functionality. Med Chem Res 2018; 27:458–69.
  • Gad-Elkareem MAM, Othman I. Synthesis and antimicrobial evaluation of some new thienopyrazoles, pyrazolothienopyridines and pyrazolothienopyrimidines via Gewald reaction. Int J Pharma Sci 2017; 7:1808–16.
  • Hassan AS, Askar AA, Nossier ES, et al. Antibacterial evaluation, in silico characters and molecular docking of Schiff Bases derived from 5-aminopyrazoles. Molecules 2019; 24:3130.
  • Khalifa NM, El-Sayed AS, Abd El-Karim SS, et al. 1,3,4-Triarylpyrazoles containing 2-thioxoimidazolidinones and different fused systems: synthesis and antimicrobial activity. Russ J Gen Chem 2018; 88:2646–52.
  • Ibrahim HS, Eldehna WM, Abdel-Aziz HA, et al. Improvement of antibacterial activity of some sulfa drugs through linkage to certain phthalazin-1(2H)-one scaffolds. Eur J Med Chem 2014; 85:480–6.
  • El-Naggar M, Sallam HA, Shaban SS, et al. Design, synthesis, and molecular docking study of novel heterocycles incorporating 1,3,4-thiadiazole moiety as potential antimicrobial and anticancer agents. Molecules 2019;24:1066.
  • The online Molinspiration software. Available from: https://www.molinspiration.com/
  • The OSIRIS property explorer software. Available from: http://www.organic-chemistry.org/prog/peo/
  • Othman IMM, Gad-Elkareem MAM, El-Naggar M, et al. Novel phthalimide based analogues: design, synthesis, biological evaluation, and molecular docking studies. J Enzy Inh Med Chem 2019; 34:1259–70.
  • Molecular Operating Environment (MOE), Version 2008.10. Montreal (QC): Chemical Computing Group Inc. Available from: https://www.chemcomp.com/MOEMolecular_Operating_Environment.htm
  • Elzahabi HAS, Nossier ES, Khalifa NM, et al. Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold. J Enzy Inh Med Chem 2018; 33:546–57.
  • Lewis WS, Cody V, Galitsky N, et al. Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of Leucine 22. J Bio Chem 1995; 270:5057–64.